1. Home
  2. ECOR

ECOR

electroCore Inc.

Logo electroCore Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Founded: 2005 Country:
United States
United States
Employees: N/A City: ROCKAWAY
Market Cap: 33.9M IPO Year: 2018
Target Price: $15.00 AVG Volume (30 days): 11.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.42 EPS Growth: N/A
52 Week Low/High: $3.83 - $8.08 Next Earning Date: 05-01-2024
Revenue: $16,030,000 Revenue Growth: 86.57%
Revenue Growth (this year): 50.2% Revenue Growth (next year): 42.62%

Share on Social Networks: